Incyte (INCY) Inventory Average (2012 - 2026)
Incyte's (INCY) quarterly Inventory Average came in at $114.1 million in Q2 2026, up 54.77% YoY from $73.7 million in Q2 2025, and up 5.3% on a QoQ basis from $108.3 million in Q1 2026.
Incyte (INCY) Inventory Average (2012 - 2026) Analysis & Trends
Incyte (INCY) has 15 years of Inventory Average data on file, last reported at $114.1 million in Q2 2026.
- Quarterly Inventory Average rose 54.77% year-over-year to $114.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $114.1 million (up 54.77% YoY) and the FY2025 annual result came in at $80.0 million, up 31.26% from the prior year.
- Inventory Average climbed to $114.1 million in Q2 2026, from $108.3 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $114.1 million in Q2 2026 to a low of $31.7 million in Q1 2022.
- A 5-year average of $65.9 million and a median of $62.4 million in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average surged 169.47% — and 2023, when it declined 14.63%.
- Tracing INCY's Inventory Average over 5 years: stood at $43.9 million in 2022, then soared by 36.72% to $60.1 million in 2023, then gained by 7.61% to $64.7 million in 2024, then soared by 42.68% to $92.3 million in 2025, then advanced by 23.66% to $114.1 million in 2026.
- The last three Inventory Average figures came in at $114.1 million (Q2 2026), $108.3 million (Q1 2026), and $92.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Incyte | 24.15 Bn | 19.61 Bn | 1.57 Bn | 114.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114.08 Mn |
| Mar 31, 2026 | 108.34 Mn |
| Dec 31, 2025 | 92.25 Mn |
| Sep 30, 2025 | 83.44 Mn |
| Jun 30, 2025 | 73.71 Mn |
| Mar 31, 2025 | 61.44 Mn |
| Dec 31, 2024 | 64.66 Mn |
| Sep 30, 2024 | 85.57 Mn |
| Jun 30, 2024 | 82.17 Mn |
| Mar 31, 2024 | 63.31 Mn |
| Dec 31, 2023 | 60.09 Mn |
| Sep 30, 2023 | 46.57 Mn |
| Jun 30, 2023 | 38.42 Mn |
| Mar 31, 2023 | 41.45 Mn |
| Dec 31, 2022 | 43.95 Mn |
| Sep 30, 2022 | 50.20 Mn |
| Jun 30, 2022 | 45.00 Mn |
| Mar 31, 2022 | 31.70 Mn |
| Dec 31, 2021 | 24.60 Mn |
| Sep 30, 2021 | 19.00 Mn |